Plrx earnings
Webb10 apr. 2024 · These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include … WebbFör 1 dag sedan · Within the last quarter, Pliant Therapeutics PLRX has observed the following analyst ratings: Bullish ... Some analysts publish their predictions for metrics such as growth estimates, earnings, ...
Plrx earnings
Did you know?
Webb8 mars 2024 · Corporate Profile. Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel therapeutics that seek to halt progression of fibrotic diseases — ultimately preserving organ function. Webb28 mars 2024 · Pliant Therapeutics released its earnings results on Mar 09, 2024. The company reported -$0.72 earnings per share for the quarter, missing the consensus …
Webb12 apr. 2024 · SOUTH SAN FRANCISCO, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive … WebbFör 1 dag sedan · Nearby homes similar to 157 Los Angeles Ave have recently sold between $870K to $1M at an average of $495 per square foot. SOLD MAR 15, 2024. $1,100,000 Last Sold Price. 9 Beds. 8 Baths. — Sq. Ft. 2009 Mariposa, Oxnard, CA 93036. SOLD MAR 3, 2024.
Webb13 apr. 2024 · NASDAQ:PLRX opened at $25.40 on Wednesday. Pliant Therapeutics has a 1 year low of $3.96 and a 1 year high of $36.64. The company has a current ratio of 14.23, a quick ratio of 14.23 and a... WebbPliant Therapeutics Inc. analyst estimates, including PLRX earnings per share estimates and analyst recommendations.
WebbPLRX earnings history information, presented by NextEarningsDate.com. Period Earnings Date GAAP; Q3 2024: 11/8/2024-0.650: Q2 2024: 8/8/2024-0.820: Q1 2024
Webb12 apr. 2024 · NasdaqGS:PLRX Earnings and Revenue Growth April 12th 2024 Pliant Therapeutics is well known by investors, and plenty of clever analysts have tried to predict the future profit levels. If you are thinking of buying or selling Pliant Therapeutics stock, you should check out this free report showing analyst consensus estimates for future profits . shark tank sippy cup lollacupWebb10 apr. 2024 · Pliant Therapeutics Shares Surge Premarket on Positive Study Data >PLRX Jan. 23, 2024 at 6:19 a.m. ET Pliant's stock gains 41% after sharing positive data about … shark tanks in homesWebb8 nov. 2024 · Pliant Therapeutics, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.48 million for the quarter ended September 2024, missing the Zacks Consensus... shark tank sliding tricycleWebbPLRX support price is $24.57 and resistance is $26.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one … population jonesboro arWebb12 apr. 2024 · For their last quarter, Pliant Therapeutics (PLRX) reported earnings of -$0.72 per share, missing the Zacks Consensus Estimate of -$0.70 per share. This reflects a … population kc metro areaWebb9 mars 2024 · Pliant Therapeutics, Inc. (PLRX) SEC Filing 10-K Annual Report for the fiscal year ending Saturday, December 31, 2024. Home. SEC Filings. ... 2024 as an 8K 2.02 … shark tank slippers animalsWebbPliant Therapeutics, Inc. (NASDAQ:PLRX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates May 13. First quarter 2024 earnings released: … shark tank simply fit board episode